Oxford-AstraZeneca vaccine begins a trial for children. It’s the youngest group yet to be tested.

Oxford-AstraZeneca vaccine begins a trial for children. It’s the youngest group yet to be tested.

Washington Post

Published

The trial will include 300 child volunteers ages 6 to 17, with 240 of them receiving the vaccine.

Full Article